Please login to the form below
biopharma
This page shows the latest biopharma news and features for those working in and with pharma, biotech and healthcare.
Researchers call on Pfizer to delay COVID-19 vaccine application
In the pledge, the biopharma leaders promised to 'only submit (a vaccine) for approval or emergency use authorisation after demonstrating safety and efficacy through a phase 3 clinical study that is
Latest news
-
RedHill Biopharma’s SK2 inhibitor shows promise against coronavirus
RedHill Biopharma has announced that its experimental sphingosine kinase-2 (SK2) opaganib demonstrated potent inhibition of SARS-CoV-2 in an in vitro clinical test.
-
Top biopharma CEOs sign COVID-19 vaccine safety pledge
Leaders promise to uphold rigorous safety and efficacy protocols
-
Sanofi bolsters pipeline with $3.7bn deal for Principia Biopharma
French drugmaker Sanofi has further bulked up its pipeline after announcing plans to acquire US-based Principia Biopharma in a deal worth $3.7bn.
-
RedHill Biopharma advances phase 2/3 COVID-19 programme
Submits clinical trial applications in Mexico and Brazil. Israeli biopharmaceutical company RedHill Biopharma has announced that it has accelerated its COVID-19 programme with the submission of new clinical trial applications
-
GSK signs deal with Medicago for COVID-19 vaccine
Collaboration will utilise GSK’s pandemic adjuvant platform. GlaxoSmithKline (GSK) continues to strengthen its position in COVID-19 research and development, with a new vaccine candidate collaboration forged with Canadian biopharma
More from news
Approximately 20 fully matching, plus 440 partially matching documents found.
Latest Intelligence
-
The impact of COVID-19 on clinical trials
loss). Biopharma companies seem to be primarily focused on pausing or delaying trials that are in patient recruitment or planning stages.
-
AI and genomics: a revolution in drug discovery and development
The omics approach could also help biotech companies attract acquisitive biopharma companies.
-
COVID-19: the race to find a vaccine
How biopharma is working to bring an end to the pandemic.
-
Biopharma and orphan drugs
Nevertheless, the consensus is that EMA and FDA programmes designed to encourage biopharma to develop medicines for smaller patient populations – primarily the orphan designation – are working. ... While there are differences in the specific
-
As COVID-19 takes over the world, biopharma fights back
Biopharma companies across the world unite in the race to find an effective COVID-19 treatment.
More from intelligence
Approximately 1 fully matching, plus 83 partially matching documents found.
Latest appointments
-
New hires at Crescendo, Healx and Galecto
Prior to joining Healx, he worked as CMO at Aparito and as therapeutic area head of orphan drugs at Mereo BioPharma.
-
New hires at FibroGen, Saniona and Turbine
Jenkins is a biopharma thought leader with over 25 years of industry experience, whose leadership roles have included global head of R&D at Merck Serono, and several senior positions at
-
New hires at Bristol-Myers Squibb, Acceleron and FerGene
While at Ipsen, Meek led a growth strategy of financial results and pipeline advancement and transformed the company into a global biopharma leader.
-
New faces at Healthware Group and HRW
ups, biopharma companies, technology firms and others. She will be based in New York City, US.
-
Health comms agency emotive hires new cell and gene therapy leader
An expert in cell and gene therapies, Dr Ferrari joins emotive following 20 years in research as well as holding medical affairs and commercial roles in biopharma and diagnostics.
More from appointments
Approximately 8 fully matching, plus 142 partially matching documents found.
Latest from PMHub
-
Webinar: How to develop an optimal value story for your product
Expert panelists: . Marcus Dahlman, European Head of Market Access at Hansa Biopharma.
-
Can patient insights improve clinical trial recruitment strategies?
According to The Patient Gap, a report developed from the analysis of three proprietary studies, 6% of healthcare clients hold the belief that biopharma companies are on their side.
-
The role of medical affairs in positive and appropriate engagement with patient advocacy groups
Biopharma recognises the importance of positive engagement and partnership with patient groups. ... A question remains around how, and which part of a biopharma organisation should be involved in building patient group relationships.
-
The changing face of pharma in the precision era
Blue Latitude Health speaks to Nancy Brandt, a Senior Leader in Global Medical Information at a top 20 biopharma organisation. ... While medical affairs teams are usually focused on developing scientific communications about a product or service for
-
Precision medicine from concept to clinic
Nancy Brandt explains how a top biopharma company is transforming internally to ensure it sits at the forefront of innovation.
More from PMHub
Approximately 1 fully matching, plus 14 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- How will the events and exhibitions industry change post-Coronavirus?
- New study identifies drugs that are safe to use in COVID-19 treatment
- Keytruda doubles five-year survival rate in NSCLC
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Novacyt launches diagnostic test to differentiate between COVID-19 and flu
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
PMHub
Fishawack Group of Companies
The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...
Latest intelligence
- Switzerland: a life sciences hub
- Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...
- Responding to dynamic shifts in value communications
- OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies....
- Doing what we can and having fun doing it: our fundraising month
- Charities are facing a number of challenges just to stay afloat amidst the current COVID-19 pandemic. Fundraisers are being cancelled and public donations are not as abundant as they have...
Quick links
Infographics
